ADR Program for Foreign Investors

Hypera Pharma implemented its Level I ADR (American Depositary Receipt) program on May 26, 2010, aiming to expand the access to investors, especially those based outside Brazil, as well as to increase the liquidity of its shares.

Hypera Pharma ADRs are traded under the ticker HYPMY and counts on J.P. Morgan Chase Bank, N.A. as depositary bank and on Itaú Unibanco S.A. as custodian institution.

For holders of ADRs registered in the depositary bank, please contact:

Banco Itaú S.A.
Address: Rua Ururaí, 111 Prédio B – Térreo, São Paulo – SP, Brazil

E-mail: dr.itau@itau-unibanco.com.br

Phone: +55 11 2740-2840